Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-wound Vancomycin Powder for SSI Prevention in Open Posterior Spinal Surgery
NCT03839914Active, not recruiting
- Sponsor
- The University of Hong Kong
- Start
- Aug 2020
- Primary completion
- Mar 2027
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of vancomycin in surgical site infection (SSI) (2 arms), sponsored by The University of Hong Kong. Primary endpoints: Incidence of superficial incisional surgical site infection at 1 year, Incidence of deep incisional surgical site infection at 1 year and 1 more. Started Aug 2020; status: active, not recruiting.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03839914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03839914.